Pediatrix Medical Group, Inc.
Income Statement
| Line Item | FY2017 | FY2016 |
|---|---|---|
| Revenue | $3.25B | $3.18B |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| Gross Margin | — | — |
| Operating Expenses | ||
| Research & Development | — | — |
| SG&A Expense | $385.9M | $372.6M |
| Operating Income | $454.9M | $571.7M |
| Operating Margin | 14.0% | 18.0% |
| Interest Expense | $74.6M | $63.1M |
| Pretax Income | $385.7M | $513.8M |
| Income Tax Expense | $80.2M | $189.2M |
| Net Income | $320.4M | $324.9M |
| Net Margin | 9.8% | 10.2% |
| EPS (Basic) | $3.47 | $3.52 |
| EPS (Diluted) | $3.45 | $3.49 |
| Shares Outstanding (Basic) | 92.4M | 92.4M |
| Shares Outstanding (Diluted) | 93.0M | 93.1M |
| Dividends Per Share | — | — |